rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Pilgrim's Pride Corporation

PPC · Nasdaq

Consumer StaplesFood ProductsSetting up

PPC stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 2.7% below that average now. Food Products: 18% of its 55 stocks in an uptrend (−7 points in four weeks); Consumer Staples: 24% (+1 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 52
Industry in uptrend
18% -7 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$606K
Officials’ trades on record
1
Institutions holding
315 (-8)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
10%22%35%Apr 26Jun 26Jul 26Sep 26Oct 26

Food Products: Few of its stocks are in an uptrend and the share has been slipping. Consumer Staples: A minority of its stocks are in an uptrend and the share has held steady.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$3.1M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 1, Senate 0, executive 0; 1 people.

WhoDidAmountTraded
Peter Meijer House: U.S. House ClerkMI03sold$1k26 Jan 2021filed 30 Dec 2022

Insiders

Buy orders, 12 months0
Sale orders, 12 months1
Buyers · sellers0 · 1
WhoDidSharesTraded
Matthew R. GalvanoniChief Financial Officersold6,963at $43.5218 Feb 2026filed 4 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders315-8 on the quarter
New · exited79 · 88
Reported value$1.4B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20264,942,584$138.9M+335,485+7.3%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20264,798,918$134.9M+968,864+25.3%
D. E. Shaw & Co., Inc.added · filed 14 Aug 20264,702,462$132.2M+1,123,415+31.4%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20262,843,438$79.9M-586,685−17.1%
AQR CAPITAL MANAGEMENT LLCreduced · filed 14 Aug 20262,159,987$60.7M-527,293−19.6%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20262,124,932$59.7M+14,271+0.7%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 20261,910,894$53.7M+373,798+24.3%
Carrhae Capital LLPnew · filed 15 Jul 20261,856,460$52.2M+1,856,460
MORGAN STANLEYadded · filed 13 Aug 20261,537,833$43.2M+256,582+20.0%
STATE STREET CORPreduced · filed 7 Aug 20261,483,749$41.7M-228,769−13.4%
31 Mar 2023 – 30 Jun 2026
170268366Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Arquimedes Celis Company insiderDirector · last 29 Apr 20260 · 0
Farha Aslam Company insiderDirector · last 29 Apr 20260 · 0
Gilberto Tomazoni Company insiderDirector · last 29 Apr 20260 · 0
Joesley Mendonca Batista Company insiderDirector, 10% owner · last 29 Apr 20263 · 0
Karoleski Joanita Maria Maestri Company insiderDirector · last 29 Apr 20260 · 0
Nogueira de Souza Andre Company insiderDirector · last 29 Apr 20260 · 0
Raul Padilla Company insiderDirector · last 29 Apr 20260 · 0
wallim cruz de vasconcellos Jr. Company insiderDirector · last 29 Apr 20260 · 0
Wesley Mendonca Batista Company insiderDirector, 10% owner · last 29 Apr 20263 · 0
Matthew R. Galvanoni Company insiderChief Financial Officer · last 18 Feb 20260 · 5
Fabio Sandri Company insiderPresident and CEO · last 17 Feb 20260 · 12
Ajay Menon Company insiderDirector · last 3 Sep 20250 · 0

Same industry

UTZ Utz BrandsLeading+38%
MED MedifastIn trend+5%
LW Lamb Weston HoldingsJust started moving+16%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 28 Dec 202512.7%
Operating profit marginFY 2025 · to 28 Dec 20258.7%
Free cash flow marginFY 2025 · to 28 Dec 20253.5%
Return on capital employedFY 2025 · to 28 Dec 202521.6%
Cash conversionFY 2025 · to 28 Dec 2025127%
Debt to equityFY 2025 · to 28 Dec 20250.00×
Interest coverFY 2025 · to 28 Dec 202510.00×
Research spendFY 2025 · to 28 Dec 20250.1%
Share count trendFY 2025 · to 11 Feb 20260.0%
Cash and equivalentsFY 2025 · to 28 Dec 2025$640.2M
Free cash flowFY 2025 · to 28 Dec 2025$653.1M

Analyst forecasts

No analyst forecasts yet.